REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $384,899 | -33.0% | 3,775 | -40.3% | 0.01% | -26.3% |
| Q1 2023 | $574,614 | +62.7% | 6,320 | -32.0% | 0.02% | +46.2% |
| Q4 2022 | $353,117 | +49.6% | 9,295 | -1.0% | 0.01% | +44.4% |
| Q3 2022 | $236,000 | -24.6% | 9,387 | -9.0% | 0.01% | -18.2% |
| Q2 2022 | $313,000 | -52.4% | 10,315 | +57.6% | 0.01% | -45.0% |
| Q3 2021 | $658,000 | -26.9% | 6,544 | +2.9% | 0.02% | -25.9% |
| Q2 2021 | $900,000 | +107.9% | 6,360 | +46.4% | 0.03% | +92.9% |
| Q1 2021 | $433,000 | -5.7% | 4,345 | +17.0% | 0.01% | -12.5% |
| Q4 2020 | $459,000 | – | 3,715 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |